Tenaya Therapeutics Financials - Benzinga

Tenaya Therapeutics Inc

TNYANASDAQ

Trade with Public

Trade with Public

$0.6832

-0.0121-1.74%

At close: Sep 4, 5:00 PM EST

$0.6850

0.00180.26%

After Hours: Sep 4, 7:55 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Tenaya Therapeutics Financials

Tenaya Therapeutics (TNYA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Tenaya Therapeutics Q2 EPS $(0.20) Misses $(0.05) Estimate, Sales $1.110M Miss $10.000M Estimate

Tenaya Therapeutics (NASDAQ:TNYA) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.05) by 300 percent. This is a 42.86 percent decrease over losses of $(0.14) per share

Benzinga Newsdesk

Earnings Scheduled For May 6, 2026

Benzinga Insights

PRO
Tenaya Therapeutics Q1 EPS $(0.09) Misses $(0.06) Estimate, Sales $25.000M Beat $10.000M Estimate

Tenaya Therapeutics (NASDAQ:TNYA) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.06) by 50 percent. This is a 62.5 percent increase over losses of $(0.24) per share from

Benzinga Newsdesk

PRO
Tenaya Therapeutics Q4 EPS $(0.12) Beats $(0.13) Estimate

Tenaya Therapeutics (NASDAQ:TNYA) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.13) by 9.09 percent. This is a 57.14 percent increase over losses of $(0.28) per share

Benzinga Newsdesk

Dow Rises Over 100 Points; Lululemon Posts Upbeat Q3 Earnings

Avi Kapoor

PRO
Tenaya Therapeutics Q3 EPS $(0.12) Beats $(0.15) Estimate

Tenaya Therapeutics (NASDAQ:TNYA) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 22.58 percent. This is a 60 percent increase over losses of $(0.30) per share from

Benzinga Newsdesk